spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  myocardial ischemia 

 HSMN NewsFeed - 20 Sep 2019
CHMP Issues Positive Opinion to Expand Trulicity(R) (dulaglutide) Label to Include Results from REWIND Cardiovascular Outcomes Trial
Biopharmaceuticals Endocrinology Cardiology Regulatory
 HSMN NewsFeed - 11 Dec 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Oct 2018
FDA Approves KYPROLIS(R) (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone (Kd70) For Patients With Relapsed Or Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Dec 2017
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 10 Oct 2016
First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma Show SUTENT(R) (sunitinib) Extended Disease Free Survival After Surgical Removal
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jul 2016
European Commission Approves Extended Indication For Amgen's Kyprolis(R) (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 2 May 2016
Corsens Medical Ltd., Announces Filing of a 510(k) Pre-Marketing Notification with the US Food and Drug Administration for the Corsens Cardiac Monitor
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 11 Nov 2014
BioCardia(R), Inc. Announces FDA Acceptance of Phase III Clinical Trial Protocol Studying Bone Marrow-Derived Cell Therapy for Heart Failure Patients
Regenerative Medicine Cardiology FDA
 HSMN NewsFeed - 16 Oct 2014
FDA Approves Boehringer Ingelheim's OFEV(R) (nintedanib) as First Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Apr 2014
Endo Acquires Rights to Sumavel(R) DosePro(R)
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 17 Mar 2014
BioCardia(R) Receives CE Mark for Morph AccessPro(TM) Steerable Introducer
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 12 Mar 2014
Toshiba’s Exclusive CT Myocardial Perfusion Helps Produce Faster and Safer Cardiac Diagnoses
Devices Radiology Cardiology FDA
 HSMN NewsFeed - 20 Feb 2014
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Colorectal Cancer after Resection of Liver Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Aug 2013
Bayer's Stivarga(R) (regorafenib) Tablets Approved in Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 15 May 2013
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Advanced Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Feb 2013
Intravase(R) Approval Opens Vascular Market for Cytori
Regenerative Medicine FDA
 HSMN NewsFeed - 29 Oct 2012
Bayer's Stivarga(R) (regorafenib) Tablets New Drug Application Granted Priority Review by U.S. FDA for the Treatment of Patients with Gastrointestinal Stromal Tumors
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Oct 2012
First Patient Treated in Cytori’s U.S. Cell Therapy Heart Failure Trial
Regenerative Medicine Cardiology
 HSMN NewsFeed - 27 Sep 2012
Bayer's Stivarga(R) (regorafenib) Tablets Approved by U.S. FDA for Treatment of Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Jul 2012
Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis(TM) (carfilzomib) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Feb 2012
Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition
Regenerative Medicine Cardiology
 HSMN NewsFeed - 30 Jan 2012
Cytori Receives Approval From FDA to Initiate U.S. Cardiac Cell Therapy Trial; Investigational Device Exemption (IDE) Approved for ATHENA
Regenerative Medicine Cardiology
 HSMN NewsFeed - 18 Jan 2012
Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis
Devices Cardiology
 HSMN NewsFeed - 5 Jan 2012
Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen(TM) in South Korea
Devices Wound Care Distribution
 HSMN NewsFeed - 10 Oct 2011
FDA Approves Combivent(R) Respimat(R) (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jan 2011
BioCardia elects Industry Veteran, Jay M. Moyes, to Board of Directors
Devices Regenerative Medicine Cardiology Personnel
 HSMN NewsFeed - 18 Nov 2010
BioCardia Announces CE Mark Approval of the First Stand-alone Intramyocardial Stem Cell Delivery Catheter System
Devices Cardiology Regenerative Medicine Regulatory
 HSMN NewsFeed - 15 Nov 2010
Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 11 Feb 2010
OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Feb 2010
Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 26 Jan 2010
Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell & Gene Therapy Forum
Biopharmaceuticals Cardiology Regenerative Medicine
 HSMN NewsFeed - 31 Aug 2009
sanofi-aventis: Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 12 Jun 2009
BARI 2D Study Presented at American Diabetes Association Scientific Sessions Underscores Utility of SPECT Myocardial Perfusion Imaging in Identifying Cardiovascular Risk and Evaluating Treatment Outcomes for Patients with Type 2 Diabetes
Biopharmaceuticals Radiology Cardiology
 HSMN NewsFeed - 27 May 2009
Cytori Completes Enrollment in First Adipose Stem & Regenerative Cell Therapy Trial for Chronic Heart Disease
Regenerative Medicine Cardiology
 HSMN NewsFeed - 13 Apr 2009
Arrow International Announces Worldwide Voluntary Recall of Intra Aortic Balloon Pump (IAB) Catheters
Devices Cardiology Product Recall
 HSMN NewsFeed - 30 Mar 2009
Toshiba Introduces Upgrades to the Aplio Artida to Enhance Imaging Capabilities for the Cardiac Market
Devices Cardiology
 HSMN NewsFeed - 30 Sep 2008
OrthoLogic Corp. Announces New Company Name: Capstone Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 5 Aug 2008
NewCardio Names Ihor Gussak, M.D., Ph.D., FACC Chief Medical Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 4 Jun 2008
LifeWatch Corp. Parent Company, Card Guard AG Receives Full FDA Clearance for Next-Generation LifeStar ACT III Platinum System
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 1 Apr 2008
Lipitor Provided an Unexpectedly Potent Heart Benefit in Patients with Chronic Stable Angina, According to New Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Mar 2008
King Pharmaceuticals Presents Positive Results of CorVue(TM) Phase III Clinical Trials at the American College of Cardiology (ACC) Annual Scientific Conference
Biopharmaceuticals Radiology Cardiology
 HSMN NewsFeed - 6 Feb 2008
Pfizer Presents New Data from HIV/AIDS Portfolio at Conference on Retroviruses and Opportunistic Infections
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 6 Feb 2008
POINT Biomedical Corp. First Tranche of $50 Million in Equity Financing
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 18 Dec 2007
Harvard University Completes Clinical Study of Pegasus HeartVue 6S System Heart Screening Device
Devices Cardiology
 HSMN NewsFeed - 14 Nov 2007
GSK Revises US Labeling for Avandia(R)
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 21 Oct 2007
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 16 Oct 2007
FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Oct 2007
Improved Perioperative Blood Pressure Control Associated with Reduced Risk of Kidney Dysfunction in Cardiac Surgery Patients
Biopharmaceuticals Cardiology Surgery
 HSMN NewsFeed - 10 Oct 2007
Multicenter PolyHeme Trauma Study Presented at the American College of Surgeons 93rd Annual Clinical Congress
Biopharmaceuticals
 HSMN NewsFeed - 18 Sep 2007
Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug Selzentry(TM) (Maraviroc)
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 2 Sep 2007
New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 6 Aug 2007
Pfizer's SelzentryTM (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 30 Jul 2007
GlaxoSmithKline Presents Avandia Data To FDA
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 18 Jul 2007
FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 4 Jun 2007
ONTAK(R) (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 May 2007
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 27 Mar 2007
Pivotal Phase III Findings With Investigational Drug Cleviprex(TM) (Clevidipine) Demonstrate Perioperative Blood Pressure Control In Cardiac Surgery
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Mar 2007
Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 26 Mar 2007
New Study Indicates Nicotine Patches May be Safe for Helping Patients with Coronary Artery Disease to Quit Smoking
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Feb 2007
FDA Grants Priority Review to Lovenox(R) (Enoxaparin Sodium Injection) Supplemental New Drug Application (sNDA) for Acute Heart Attack
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Feb 2007
First Heart Patient Treated in Adipose Stem Cell Trial; Cytori's Cardiovascular Stem Cell Study Initiated
Regenerative Medicine Cardiology
 HSMN NewsFeed - 7 Dec 2006
Cardium's Generx Advances to Phase 3 Following Meeting With FDA
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 23 Oct 2006
Caritas St. Elizabeth's Medical Center's Study Finds Injecting Patient's Own Stem Cells into the Heart to Treat Severe Coronary Artery Disease is Well Tolerated
Biopharmaceuticals Regenerative Medicine Cardiology
 HSMN NewsFeed - 11 Oct 2006
Stonebridge Pharma and Capellon Pharmaceuticals Announce Co-Promotion Agreement to Market Symax(TM) Duotab (hyoscyamine sulfate) for Irritable Bowel Syndrome
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 2 Oct 2006
FDA Grants Priority Review for ARIXTRA(R) (fondaparinux sodium) in the Treatment of Acute Coronary Syndromes
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 11 May 2006
Federal Appeals Court Rules in Cardium's Favor Over Boston Scientific and Arch Development on Patents for the Treatment of Heart Disease
Devices Cardiology Litigation
Return to NewsFeed  

 Additional items found! 43

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 43 additional stories matching:
myocardial ischemia
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.